Immunity of Canadians and risk of epidemics workshop - Conference report

Shelly Bolotin; Selma Osman; Scott Halperin; Alberto Severini; Brian J Ward; Manish Sadarangani; Todd Hatchette; Richard Pebody; Amy Winter; Hester De Melker; Aaron R Wheeler; David Brown; Matthew Tunis; Natasha Crowcroft

doi:10.1016/j.vaccine.2023.07.023

Immunity of Canadians and risk of epidemics workshop - Conference report

Vaccine. 2023 Oct 10:S0264-410X(23)00834-4. doi: 10.1016/j.vaccine.2023.07.023. Online ahead of print.

Authors

Affiliations

¹ Centre for Vaccine Preventable Diseases, University of Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada. Electronic address: shelly.bolotin@utoronto.ca.
² Public Health Ontario, Toronto, ON, Canada.
³ Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada; Departments of Pediatrics and Microbiology & Immunology, Dalhousie University, Halifax, NS, Canada.
⁴ National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MN, Canada; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
⁵ Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
⁶ Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
⁷ Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada; Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, NS, Canada.
⁸ Public Health England, London, United Kingdom.
⁹ University of Georgia, Athens, GA, United States.
¹⁰ National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
¹¹ Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
¹² Virus Reference Department, UK Health Security Agency, London, United Kingdom; Laboratório de Vírus Respiratórios e do Sarampo, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Brazil.
¹³ National Advisory Committee on Immunization Secretariat, Public Health Agency of Canada, Ottawa, Ontario, Canada.
¹⁴ Centre for Vaccine Preventable Diseases, University of Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.

PMID: 37827968
DOI: 10.1016/j.vaccine.2023.07.023

Abstract

On November 18-19, 2019, the Immunity of Canadians and Risk of Epidemics (iCARE) Network convened a workshop in Toronto, Ontario, Canada. The objectives of the workshop were to raise the profile of sero-epidemiology in Canada, discuss best practice and methodological innovations, and strategize on the future direction of sero-epidemiology work in Canada. In this conference report, we describe the presentations and discussions from the workshop, and comment on the impact of the COVID-19 pandemic on serosurveillance initiatives, both in Canada and abroad.

Keywords: Sero-epidemiology; Serosurveillance; Vaccine-preventable diseases.

Publication types

Clinical Conference